Ice Bear Therapeutics SPC Email Formats

About Ice Bear Therapeutics SPC

Mission: Ice Bear Therapeutics is on a mission to revolutionize the unmet need for insulin. Over 8.4 million diabetics battle to get access to affordable insulin to survive in the US. In 030 there will be an estimated 40 million diabetics in need of insulin. The estimated future need for insulin in the United States is over 160 million patients. Current manufacturing processes take at least 3 months with large amounts of waste and will likely not be able to meet the future demand. Insulin manufacturing has remained resource and cost intensive, until now.. Ice Bear Therapeutics has developed a patented continuous manufacturing process that is up to 90 times faster and 10 times cheaper than current manufacturing. This process consumes far less resources and allows for much greater volume in shorter periods of time. Ice Bear Therapeutics is committed to bring affordable, high-quality insulin to the market place in the next few years, meeting the demand needs of its customers. Ice Bear intends to be the predominant provider of biosimilar insulin for the world. About: Ice Bear Therapeutics is headquartered in Seattle, Washington in the United States of America. We have global manufacturing partners in the USA and India. Ice Bear is a registered Social Purpose Company. We believe by lowering our cost of goods and significantly increasing supply, we can meet the demand needs of our customers with reasonable pricing.

View contact profiles from Ice Bear Therapeutics SPC